The dental bone graft and substitutes market is growing exponentially in recent years. This can be attributed to increasing focus on aesthetic appeal and increasing dental visits. Demineralized bone matrix, allograft, xenograft, and synthetic bone graft substitutes form the product type segment in the market.
Market Dynamics
Increasing focus on aesthetic appeal is expected to propel growth of the dental bone graft and substitutes market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing number of dentist visits is also expected to aid in growth of the market. For instance, according to National Center for Health Statistics’ 2018 report, 84.9% of children aged 2-17 years visited a dentist in 2017, in the U.S.
High prevalence of dental disorders is expected to offer lucrative growth opportunities for players in the dental bone graft and substitutes market. For instance, according to the Centers for Diseases Control and Prevention’s Oral Health Surveillance Report, 2019, the prevalence of untreated tooth decay in primary teeth was 10% among children aged 2–5 years and 16% among those 6–8 years during 2011-2016. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Among regions, North America is expected to witness significant growth in the dental bone graft and substitutes market, owing to increasing approval and launch of new products. For instance, in July 2020, Baxter International Inc. received the U.S. FDA approval of Altapore Shape Bioactive Bone Graft — the latest addition to the company’s next-generation bone graft substitute product line.
Competitive Analysis
Major players operating in the dental bone graft and substitutes market include, Institut Straumann AG, Geistlich, DENTSPLY International, Zimmer Biomet, Medtronic Plc., BioHorizons IPH, Inc., ACE Surgical Supply Company, Inc., RTI Surgical, Inc., LifeNet Health, and Citagenix
Major players operating in the dental bone graft and substitutes market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2020, Spine Wave launched Tornado Bioactive Bone Graft Matrix, which complements Spine Wave’s recently launched Tempest Allograft Bone Matrix, and each of these technologies work seamlessly with the company’s GraftMag Graft Delivery System.
No comments:
Post a Comment